Company: CRNX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-029050
Chunk: 41

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 41
---
 dated as of September 9, 2022, by and between San Diego 1 LLC and the Registrant
     
    10-K

    2/28/2024

    10.14

    10.14#
     
    Non-Employee Director Compensation Program, as amended April 24, 2023
     
    10-Q

    5/09/2023

    10.2

    10.15#
     
    Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan and Form of Stock Option Agreement thereunder
     
    8-K

    12/23/2021

    10.1

    10.16#
     
    Amendment to the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan
     
    10-Q

    11/14/2022

    10.3

    10.17#
     
    Amendment No. 2 to the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan
     
    10-K

    2/28/2023

    10.19

    10.18#
     
    Amendment No. 3 to the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan
     
    10-Q

    11/7/2023

    10.1

    10.19#
     
    Amendment No. 4 to the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan

    X

F-31

    10.20#
     
    Form of restricted stock unit agreement under Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan
     
    10-K

    3/30/2022

    10.17

    10.21#
     
    Crinetics Pharmaceuticals, Inc. Excess Deferral Plan Adoption Agreement 
     
    10-Q

    5/9/2024

    10.1

    10.22#
     
    Amended and Restated Employment Agreement, effective as of May 22, 2018, by and between Stephen Betz and the Registrant 
     
    10